Novartis Ag(FRA) NOTA

Market Cap€245.29B

Since IPON/A

5 YearN/A

1 YearN/A

1 MonthN/A

€130.00

-0.76%

-1.00Today

Novartis Ag Financials at a Glance

Market Cap

€245.29B

Revenue (TTM)

€46.96K

Net Income (TTM)

€10.93K

EPS (TTM)

€5.68

P/E Ratio

23.45

Dividend

€4.10

Beta (Volatility)

-0.05 (Low)

Dividend

€4.10

Beta (Volatility)

-0.05 (Low)

Price

€130.00

Volume

Open

€130.00

Price

€130.00

Volume

Open

€130.00

Previous Close

€130.00

Daily Range

€130.00 - €130.00

52-Week Range

€101.50 - €145.00

Estimated Earnings Date

N/A

Dividend

€4.10

Beta (Volatility)

-0.05 (Low)

Price

€130.00

Volume

Open

€130.00

Previous Close

€130.00

Daily Range

€130.00 - €130.00

52-Week Range

€101.50 - €145.00

Estimated Earnings Date

N/A

NOTA News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Novartis Ag

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Industry

Pharmaceuticals

Sector

Health Care

Employees

75,267

CEO

Vasant Narasimhan, MD

Website

www.novartis.com

NOTA Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

30.33%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

4.26%

Dividend Yield

3.06%

Payout Ratio

N/A

Stock Overview

Market Cap

€245.29B

Shares Outstanding

1.83B

Volume

Avg. Volume

27.121

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Novartis Ag Performance Analysis

Novartis Ag annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	EUR 40,158,936,717	-8.1%
2023	2023-12-31	EUR 42,030,629,760	4.7%
2024	2024-12-31	EUR 46,516,963,636	10.7%
2025	2025-12-31	EUR 48,319,208,998	3.9%

Novartis Ag annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	EUR 3.01	-66.5%
2023	2023-12-31	EUR 6.57	118.0%
2024	2024-12-31	EUR 5.42	-17.4%
2025	2025-12-31	EUR 6.34	16.8%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

€12.39K

+1.0%

Gross Profit

€9.23K

+1.0%

Gross Margin

74.47%

+1.0%

Market Cap

€245.29B

N/A

Market Cap/Employee

€3.31

N/A

Employees

75,267

N/A

Net Income

€2.80K

+0.8%

EBITDA

€5.10K

+1.0%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

€49.53K

+48.0%

Total Debt

€42.87K

+1.5%

Accounts Receivable

€8.43K

+1.1%

Inventory

€5.44K

+1.0%

Long Term Debt

€34.24K

+1.7%

Short Term Debt

€8.63K

+1.2%

Return on Assets

11.18%

+0.8%

Return on Invested Capital

16.41%

+1.1%

Free Cash Flow

€4.81K

+0.9%

Operating Cash Flow

€5.09K

+0.9%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7,684.24-0.00%

^DJIDJI

^DJIDJI$53,254.61-0.01%

^IXICNASDAQ

^IXICNASDAQ$26,319.55-0.00%

BTCBitcoin

BTCBitcoin$78,890.00-0.00%

SPCXSPCX

SPCXSPCX$142.81+0.01%

AAPLAAPL

AAPLAAPL$315.25-0.01%

AMZNAMZN

AMZNAMZN$258.45-0.03%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

PCGPG&E

PCGPG&E$13.27-0.20%

NVDANvidia

NVDANvidia$220.78+0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$9.97+0.11%

CNHCNH Industrial

CNHCNH Industrial$11.83+0.01%

NUNu Holdings

NUNu Holdings$14.55+0.02%

BITOProShares Trust - ProShares Bitcoin ETF

BITOProShares Trust - ProShares Bitcoin ETF$10.63+0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.43-0.02%

Questions About NOTA

What is the current price of Novartis Ag?

Novartis Ag is trading at €130.00 per share.

What is the 52-week range for Novartis Ag?

Over the past 52 weeks, Novartis Ag has traded between €101.50 and €145.00.

How much debt does Novartis Ag have?

As of the most recent reporting period, Novartis Ag reported total debt of €42.87B.

How much cash does Novartis Ag have on hand?

Novartis Ag reported €6.66B in cash and cash equivalents in its most recent financial results.

What is Novartis Ag’s dividend yield?

Novartis Ag currently has a dividend yield of 3.06%.

Novartis Ag(FRA) NOTA

Novartis Ag Financials at a Glance

NOTA News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Novartis Ag

NOTA Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Novartis Ag Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About NOTA

What is the current price of Novartis Ag?

What is the 52-week range for Novartis Ag?

How much debt does Novartis Ag have?

How much cash does Novartis Ag have on hand?

What is Novartis Ag’s dividend yield?

Premium Investing Services